Remote SaaS & Pharma Consulting Business with Recurring Revenue

View Original Listing

Financial Details

Asking Price:
$1,200,000
Annual Revenue:
$808,104
Cash Flow / SDE:
$273,876
Profit Metric:
Adjusted EBITDA
Valuation Multiple:
4.4x
Location:
DE
Source:
Date:
October 17, 2025

Key Highlights

Strong recurring revenue stream supported by proprietary SaaS licensing.
Established client base including major pharmaceutical leaders like Novo Nordisk and GSK.
Demonstrated high growth rate of 18.5% YoY between 2023 and 2024.

Description

This is an established, Germany-headquartered, fully remote SaaS and Consulting firm founded in 2017, specializing in providing proprietary software solutions and expert consulting services to mid-to-large pharmaceutical companies globally. The business features a balanced revenue model combining high-value consulting projects and stable, recurring SaaS license fees. Key clients include industry leaders such as Novo Nordisk, Sanofi, and GSK. The firm operates with a scalable remote team of 3-6 employees and achieved an impressive 18.5% year-over-year revenue growth between 2023 and 2024. The asking price is $1,200,000, calculated based on a 4.4x multiple of the $273,876 Adjusted EBITDA.

Industry Information

Industry Description:
Technology company providing specialized SaaS platforms and consulting services to the pharmaceutical sector, characterized by recurring licensing revenue.
Classification:
Online & Technology

Operational Snapshot

Year Established:
2017
Employees:
6

Real Estate & Lease

Status:
Not_applicable

Assets & Inventory

Includes FF&E:
No
Includes Inventory:
No

Listing Details

Listing ID:
d726e9cc-5032-4df9-87af-7fdf10bc632c
Deal Status:
For Sale
Last Updated:
October 17, 2025
Currency:
USD

Features & Tags

Quality Verified This listing meets our quality criteria and standards. Verified